Company intelligence / Profile preview

BioScan Screening Systems

Smyrna, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

BioScan Screening Systems, Inc. was a medical diagnostic company specializing in point-of-care (POC) drug screening and urine adulteration testing. Based in Smyrna, Tennessee, the company developed and manufactured rapid, non-instrumental immunoassay products for workplace, forensic, and clinical applications. Its notable products included the iCup integrated drug test cup, the Rapid Drug Screen multi-panel test, and the Intect 7 and AdultaCheck adulteration dipsticks. The company's technologies focused on lateral flow assays and immunochromatographic methods to provide fast, reliable results for detecting drugs of abuse and ensuring sample validity.

Therapeutic areas: PsychiatryOther
Modalities: DeviceImmunoassayLateral Flow Assay
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on BioScan Screening Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioScan Screening Systems.

Explore the full profile